Clinical trial
The Value of a Tailored-based, Exercise Program for Improving Quality of Life of Patients With Hematologic Malignancies: a Pilot Randomized Trial
NCT07912684 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Value of a Tailored-based, Exercise Program for Improving Quality of Life of Patients With Hematologic Malignancies: a Pilot Randomized Trial
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 10, 2026
- Completion date
- November 10, 2028
- Enrollment
- 75 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia, lymphoma, multiple myeloma
Arms
As registered; 2 arms.
-
Structured Exercise Program (SEP)
Participants randomized to the intervention group will receive a 16-week personalized, supervised, hybrid structured exercise program (SEP), combining home- and gym-based training. The program includes aerobic, resistance, balance, and stretching exercises, a structured walking program, and behavioral counseling. Exercise sessions will be supervised by trained exercise professionals, either in person or remotely, according to the intervention phase.
-
Control
Participants randomized to the control group will receive usual care and general information about the benefits of physical activity. They will not participate in the supervised structured exercise program during the study period.
Primary endpoints
Registered primary outcome measures; 2 primary.
-
Adherence to the Structured Exercise Program
Adherence will be assessed as the percentage of participants in the intervention group who attend at least 65% of the planned supervised exercise sessions. The intervention will be considered feasible if at least 70% of participants meet this adherence t
-
Patient Satisfaction With the Structured Exercise Program
Patient satisfaction will be assessed in the intervention group using the item "Overall, I am satisfied with the exercise program" from a study-specific satisfaction questionnaire. Responses are rated on a 4-point scale: "disagree", "somewhat disagree", "somewhat agree", and "agree". Satisfaction will be measured as the percentage of participants responding "somewhat agree" or "agree". The intervention will be considered feasible if at least 75% of participants meet this satisfaction criterion.
Lead sponsor's other trials
Gruppo Italiano Malattie EMatologiche dell'Adulto, most recent start first.
+129 more trials See the organization page
Similar trials
Same condition (Multiple Myeloma) and phase, most recent start first.
+331 more trials See the condition page